Eisenstein B I
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor 48109.
J Infect Dis. 1990 Apr;161(4):595-602. doi: 10.1093/infdis/161.4.595.
A major aim of clinical microbiologists over the last century has been to demonstrate the presence of pathogenic microorganisms in clinical or pathologic samples associated with infectious diseases. With the development of molecular genetics over the last two decades, new technologies have become available that allow more sensitive and specific determinations to be made in shorter periods. Two considerable benefits have accrued: Epidemiologists are now capable of judging clonality among various clinical isolates more powerfully, permitting added accuracy in the evaluation of the epidemic spread of microbes, and clinicians have gained enormous ability to diagnose previously difficult-to-detect pathogens.
在过去的一个世纪里,临床微生物学家的一个主要目标是在与传染病相关的临床或病理样本中证明致病微生物的存在。随着过去二十年分子遗传学的发展,新技术已经出现,能够在更短的时间内进行更敏感、更特异的检测。这带来了两个显著的好处:流行病学家现在能够更有力地判断各种临床分离株之间的克隆性,从而在评估微生物的流行传播时提高准确性;临床医生在诊断以前难以检测的病原体方面也有了巨大的能力提升。